{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:52:29Z","timestamp":1795038749738,"version":"4.10.2"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1097\/rlu.0000000000001339","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T16:24:48Z","timestamp":1472055888000},"page":"787-788","source":"Crossref","is-referenced-by-count":22,"title":["Serial 18F-FDG PET\/CT Findings in a Patient With IgLON5 Encephalopathy"],"prefix":"10.1097","volume":"41","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(15)60445-7","article-title":"IgLON5 autoimmunity and abnormal behaviours during sleep","volume":"385","author":"H\u00f6gl","year":"2015","journal-title":"Lancet"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1212\/NXI.0000000000000136","article-title":"Sleep disorder, chorea, and dementia associated with IgLON5 antibodies","volume":"2","author":"Simabukuro","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1474-4422(14)70127-9","article-title":"Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia?","volume":"13","author":"Della Marca","year":"2014","journal-title":"Lancet Neurol"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mds.25926","article-title":"Friend or foe? IgLON5 antibodies in a novel tauopathy with prominent sleep movement disorder, ataxia, and chorea","volume":"29","author":"Balint","year":"2014","journal-title":"Mov Disord"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-12-20210204","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp-2014-308216","article-title":"What to see when you are looking at confusion: a review of the neuroimaging of acute encephalopathy","volume":"86","author":"Sutter","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2015.05.002","article-title":"The role of PET\/CT in the evaluation of patients affected by limbic encephalitis: a systematic review of the literature","volume":"284","author":"Quartuccio","year":"2015","journal-title":"J Neuroimmunol"},{"key":"R10-12-20210204","first-page":"201","article-title":"Brain metabolic changes in limbic encephalitis evidenced by 18FDG PET. Correlation with symptomatology","volume":"32","author":"Serrano Vicente","year":"2013","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2014.04.002","article-title":"Serial brain 18FDG-PET in anti-AMPA receptor limbic encephalitis","volume":"271","author":"Spatola","year":"2014","journal-title":"J Neuroimmunol"},{"key":"R12-12-20210204","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1097\/RLU.0000000000000839","article-title":"Monitoring the effect of immunotherapy in autoimmune limbic encephalitis using 18F-FDG PET","volume":"40","author":"Trevino-Peinado","year":"2015","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:16:15Z","timestamp":1620972975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201610000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001339","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}